None listed
Conditions
Interventions
Others(Peptides) : Test group: colorless gel liquid product consisting of hair tonic Base + adiponectin derived peptide (6 months)
Control group: colorless gel liquid product consisting solely of hai
Sponsors
Seoul National University Hospital
Eligibility
Sex/Gender
Male
Inclusion criteria
Inclusion criteria: • volunteer in writing to participate who understand the need and process of clinical trials • Among the men aged 18 to 49, Hamilton-Norwood class III, IV, V • Volunteers who can follow-up during the trial period during the trial period
Exclusion criteria
Exclusion criteria: • If you have severe acute kidney or heart disease or other chronic illness that may affect your test results in the last 6 months • Have experience with finasteride or other 5a-Reductase inhibitors within 12 months before screening. • If you have experience using plant remedies (eg saw palmetto) within 8 weeks before screening • Use of glucocorticoids within 3 months prior to screening (inhaled glucocorticoids allowed; topical steroids are allowed if not used on scalp) • Usage 6 months before screening : ? Minoxidil (oral or topical) ? Drugs with antiandrogenic properties (eg cyproterone acetate, spironolactone, ketoconazole, flutamide, and bicalutamide). Cimetidine can not be used during the trial period, but it has not been used for the last 6 months. ? Local estrogen, progesterone ? Tamoxifen ? Drugs that can cause hyperhidrosis to cause hyperactivity (eg cyclosporine, diazoxide, phenytoin psoralens) ? Anabolic steroids ? Lithium and phenothiazine • Use of past cytotoxic agents • Simultaneous or regular use of topical agents on scalp for 4 weeks before screening • Have received surgical treatment for hair loss such as hair transplantation or scalp reduction • You have used other products that have been called "hairballs" within the last 3 months. • Have recently taken or are currently taking medications that may affect hair growth • If you are suffering from alopecia due to causes other than male hair loss • Others who are unable to communicate or who are unable to follow instructions
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Hair density | — |
Secondary
| Measure | Time frame |
|---|---|
| mean hair diameter;linear hair growth rate;ratio of the anagen hair;non-vellus hair count | — |
Countries
Korea, Republic of
Contacts
Public ContactJungyoon Ohn
Seoul National University Hospital
Outcome results
None listed